These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35085792)

  • 1. Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model.
    Mishra S; Lasek-Nesselquist E; Mathur A; Ma Z; Boonthaworn K; O'Donnell N; Sui H; Pata JD; McDonough KA; Jayachandran P; Malik M
    J Glob Antimicrob Resist; 2022 Mar; 28():249-253. PubMed ID: 35085792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
    Renzoni A; Kelley WL; Rosato RR; Martinez MP; Roch M; Fatouraei M; Haeusser DP; Margolin W; Fenn S; Turner RD; Foster SJ; Rosato AE
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of
    Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
    Yang SJ; Xiong YQ; Boyle-Vavra S; Daum R; Jones T; Bayer AS
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3161-9. PubMed ID: 20547804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant
    Zhang R; Barreras Beltran IA; Ashford NK; Penewit K; Waalkes A; Holmes EA; Hines KM; Salipante SJ; Xu L; Werth BJ
    Front Mol Biosci; 2021; 8():688357. PubMed ID: 34646861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
    Mishra NN; McKinnell J; Yeaman MR; Rubio A; Nast CC; Chen L; Kreiswirth BN; Bayer AS
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4012-8. PubMed ID: 21709105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.
    Lew C; Mishra NN; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0035621. PubMed ID: 34097478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strains.
    de Carvalho CCCR; Taglialegna A; Rosato AE
    J Antimicrob Chemother; 2021 Dec; 77(1):135-147. PubMed ID: 34618036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.
    Iwata Y; Satou K; Tsuzuku H; Furuichi K; Senda Y; Sakai-Takemori Y; Wada T; Fujita S; Miyake T; Yasuda H; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Kaneko S; Wada T
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1839-1845. PubMed ID: 28477235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.
    Berti AD; Wergin JE; Girdaukas GG; Hetzel SJ; Sakoulas G; Rose WE
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5046-53. PubMed ID: 22802248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus.
    Lew C; Pellitteri Hahn M; Scarlett C; Rottier A; Berti AD; Proctor RA; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0201721. PubMed ID: 35041502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus:
    Mishra NN; Lew C; Abdelhady W; Lapitan CK; Proctor RA; Rose WE; Bayer AS
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0164921. PubMed ID: 34694870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.